Literature DB >> 2765411

Treatment of chronic myelomonocytic leukemia with low dose etoposide.

D G Oscier1, A Worsley, T J Hamblin, G J Mafti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2765411     DOI： 10.1111/j.1365-2141.1989.tb07735.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Malignant pleural effusion in chronic myelomonocytic leukaemia.

Authors:  A Manoharan
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

Review 2.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 3.  Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Authors:  Konstantinos Liapis; Ioannis Kotsianidis
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.